share_log

HC Wainwright & Co. Maintains Buy on United Therapeutics, Raises Price Target to $425

Benzinga ·  Oct 31 21:34  · Ratings

HC Wainwright & Co. analyst Andrew Fein maintains United Therapeutics (NASDAQ:UTHR) with a Buy and raises the price target from $400 to $425.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment